… of venous thromboembolism. Patients who are considered to be at particularly high risk of
venous thromboembolism … for patients at high risk of venous thromboembolism, even though …

Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism,
is a chronic illness that affects nearly 10 million people every year worldwide. Strong …

… We report on 17 systematic reviews of these trials, published between 1994 and 2003, which
reviewed rates of recurrent VTE, major bleeding, or death (11–27). Five included only trials …

… of venous thromboembolism were not included in this analysis. A prior systematic review …
for the secondary prevention of venous thromboembolism has been published. Our findings …

… words “venous thromboembolism”, “deep vein thrombosis,” and “pulmonary embolus”. We
also reviewed recent guidelines on management of venous thromboembolism and identified …

… in this systematic review, all novel oral anticoagulants and antiplatelet drugs investigated
were associated with a reduced recurrence of venous thromboembolism compared with …

… Categorization of patients as having provoked or unprovoked venous thromboembolism: …
If advances were not covered by a systematic review or meta-analysis, we included …

… referred to as venous thromboembolism (VTE) – result in a major burden on healthcare
systems. However, to the authors’ knowledge no comprehensive review of the economic burden …

… , meta-analyses, and randomized controlled trials, as well as other clinical trials for topics
not covered by the former, were reviewed. Literature searches using broad terms were used to …

… systematic review and meta-analysis of the published work. Furthermore, many studies have
investigated the management of venous thromboembolism in … done this systematic review. …